HCA Healthcare’s (NYSE:HCA) “Outperform” Rating Reaffirmed at Credit Suisse Group

Credit Suisse Group reissued their outperform rating on shares of HCA Healthcare (NYSE:HCA) in a report released on Tuesday, December 26th. The brokerage currently has a $25.00 price target on the stock.

A number of other analysts have also issued reports on HCA. Robert W. Baird reissued a buy rating on shares of HCA Healthcare in a research report on Thursday, September 28th. ValuEngine raised shares of HCA Healthcare from a hold rating to a buy rating in a research report on Monday, October 2nd. SunTrust Banks set a $105.00 price target on shares of HCA Healthcare and gave the stock a buy rating in a research report on Thursday, December 21st. Royal Bank of Canada reissued an outperform rating and issued a $90.00 price target on shares of HCA Healthcare in a research report on Thursday, October 19th. Finally, BMO Capital Markets initiated coverage on HCA Healthcare in a report on Monday, October 16th. They issued an outperform rating and a $90.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have issued a buy rating to the company’s stock. HCA Healthcare presently has an average rating of Buy and a consensus price target of $88.70.

Shares of HCA Healthcare (HCA) opened at $88.80 on Tuesday. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. HCA Healthcare has a 52 week low of $71.18 and a 52 week high of $91.03. The company has a market cap of $31,420.00, a PE ratio of 12.63, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.21. The business had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The firm’s revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. equities research analysts predict that HCA Healthcare will post 6.56 EPS for the current fiscal year.

In other HCA Healthcare news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the transaction, the insider now owns 12,476 shares in the company, valued at $973,128. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Victor L. Campbell sold 8,000 shares of the firm’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the sale, the senior vice president now owns 127,275 shares in the company, valued at approximately $9,649,990.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,700 shares of company stock worth $1,773,872. Corporate insiders own 2.90% of the company’s stock.

Institutional investors have recently made changes to their positions in the company. Strs Ohio grew its stake in shares of HCA Healthcare by 12.2% in the third quarter. Strs Ohio now owns 1,075,778 shares of the company’s stock worth $85,621,000 after acquiring an additional 117,000 shares during the last quarter. AustralianSuper Pty Ltd acquired a new stake in shares of HCA Healthcare in the third quarter worth $24,410,000. Yellowstone Partners LLC acquired a new stake in shares of HCA Healthcare in the third quarter worth $5,802,000. Toronto Dominion Bank grew its stake in shares of HCA Healthcare by 12.8% in the third quarter. Toronto Dominion Bank now owns 112,657 shares of the company’s stock worth $8,965,000 after acquiring an additional 12,744 shares during the last quarter. Finally, Micawber Capital LLC grew its stake in shares of HCA Healthcare by 31.3% in the third quarter. Micawber Capital LLC now owns 34,461 shares of the company’s stock worth $2,743,000 after acquiring an additional 8,205 shares during the last quarter. Institutional investors and hedge funds own 75.34% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “HCA Healthcare’s (NYSE:HCA) “Outperform” Rating Reaffirmed at Credit Suisse Group” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://ledgergazette.com/2018/01/13/hca-healthcare-hca-earns-outperform-rating-from-credit-suisse-group.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply